Loading clinical trials...
Loading clinical trials...
A Phase I/IIa Safety and Pharmacokinetic Study of Intravenous FIXFc in Previously Treated Hemophilia B Patients
Conditions
Interventions
rFIXFc
Locations
6
United States
RUSH University Medical Center
Chicago, Illinois, United States
Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
University of North Carolina Medical School
Chapel Hill, North Carolina, United States
Hemophilia Center of Western PA
Pittsburgh, Pennsylvania, United States
Puget Sound Blood Center
Seattle, Washington, United States
Start Date
April 1, 2008
Primary Completion Date
October 1, 2009
Completion Date
October 1, 2009
Last Updated
December 19, 2020
NCT03961243
NCT06820515
NCT06379789
NCT06008938
NCT04645199
NCT07080905
Lead Sponsor
Bioverativ Therapeutics Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions